Institutional Ownership Oramed Pharmaceuticals Inc. (ORMP)
This table provides information about the institutional ownership of Oramed Pharmaceuticals Inc. (ORMP). We have compiled data on the 59 institutions that hold shares in the stock, with a total of 5.69 Million shares, which have been reported (via 13F filing form) to have a value of $14.5 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bivin & Associates, Inc.
Ponca City, OK |
Aug 11, 2022 Q2 2022 |
800
shares
|
$2,048
0.0% of portfolio
|
Q1 2022
Added 14.29%
|
|
Newbridge Financial Services Group, Inc.
|
Apr 24, 2024 Q1 2024 |
657
shares
|
$1,681
0.0% of portfolio
|
Q4 2021
New holding
|
|
Covington Capital Management
|
Nov 14, 2022 Q3 2022 |
325
shares
|
$832
0.0% of portfolio
|
Q3 2021
New holding
|
|
Tyler Stone Wealth Management
Beachwood, OH |
May 15, 2024 Q1 2024 |
300
shares
|
$768
0.0% of portfolio
|
Q4 2021
New holding
|
|
Beacon Capital Management, LLC
|
May 16, 2024 Q1 2024 |
219
shares
|
$560
0.0% of portfolio
|
Q4 2022
New holding
|
|
Time Scale Financial, Inc.
|
Jul 26, 2023 Q2 2023 |
125
shares
|
$320
0.0% of portfolio
|
Q3 2020
Added 48.81%
|
|
Global Retirement Partners, LLC
|
Apr 23, 2024 Q1 2024 |
100
shares
|
$256
0.0% of portfolio
|
Q4 2023
New holding
|